Abstract
A hemostatic composition is provided. The hemostatic composition includes a hemostatically effective amount of a hemostatic agent that includes a nanoparticle and a polyphosphate polymer attached to the nanoparticle. Also provided are medical devices and methods of use to promote blood clotting.
Original language | English (US) |
---|---|
U.S. patent number | 11707550 |
State | Published - Jul 25 2023 |